Recruiting OBSERVATIONAL NCT06344143

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma (MACS)

Sponsor: RECORDATI GROUP

Conditions Mild Autonomous Cortisol Secretion (MACS)

Interventions Various labs and imaging tests

Updated 9 times since 2024 Last updated: Jan 6, 2026 Started: Nov 20, 2024 Primary completion: Dec 1, 2029 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Mild Autonomous Cortisol Secretion (MACS), this trial is actively recruiting participants. The trial is conducted by RECORDATI GROUP and has accumulated 9 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Dec 2025 — Feb 2026 [monthly]

Recruiting
Feb 2025 — Dec 2025 [monthly]

Recruiting
Dec 2024 — Feb 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Dec 2024 [monthly]

Not Yet Recruiting

▶ Show 4 earlier versions

Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting
Aug 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RECORDATI GROUP
The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States